Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05341739 · ClinicalTrials.gov registry record · NA
A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases
A NA study of Brain Metastases, Adult, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05341739 is a NA study of Brain Metastases, Adult that is active but no longer recruiting, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 20 participants, below the 95-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05341739, a NA study of Brain Metastases, Adult, is active but no longer recruiting, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to determine if performing stereotactic radiosurgery (SRS) prior to surgical resection of the brain metastasis (tumor) will improve local control, in other words, increase the possibility of total removal of the primary tumor without local recurrence on longterm follow up. This research study will also determine if pre-operative SRS will lower the risk of radionecrosis that is the breakdown of body tissue at the original tumor site, and the development of leptomeningeal disease.
Conditions Studied
Interventions
- OTHER Pre-operative Stereotactic Radiosurgery
Study Locations (1)
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-12-14 |
| Est. Completion | 2025-11 |
| Phase | NA |
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)34 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05341739
The ClinicalTrials.gov registry entry for NCT05341739 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 14 other Brain Metastases, Adult trials with a reported enrollment target (79% lower). The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Metastases, Adult appearing as the primary indexed condition, and to 1 intervention - of which Pre-operative Stereotactic Radiosurgery is the first listed.
NCT05341739 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05341739 about?
NCT05341739 is a clinical study titled "A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases". This is a research study to determine if performing stereotactic radiosurgery (SRS) prior to surgical resection of the brain metastasis (tumor) will improve local control, in other words, increase the possibility of total removal of the primary tumor without local recurrence on longterm follow up. T...
What is the current status of trial NCT05341739?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-12-14. Estimated completion is 2025-11.
What conditions does trial NCT05341739 study?
This clinical trial studies the following conditions: Brain Metastases, Adult.
What interventions are being tested in trial NCT05341739?
The interventions under investigation include: Pre-operative Stereotactic Radiosurgery (OTHER).
Who is sponsoring clinical trial NCT05341739?
This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05341739 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Metastases, Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Multi-disciplinary Care for Brain Metastases
RECRUITING · NA
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
RECRUITING · Phase 1
-
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
RECRUITING · Phase 2
-
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.